An increase in insulin resistance leads to a constant need for more insulin. An antihypertensive therapy that causes this contributes to a faster exhaustion of the insulin-producing cells in the pancreas. This means that with a corresponding genetic disposition, type II diabetes can manifest earlier. The antihypertensive should therefore not increase insulin resistance.